Palliative care utilization and trends among patients with metastatic breast cancer: A SEER-Medicare analysis.

被引:0
|
作者
Giap, Fantine
Hong, Young-Rock
Xie, Zhigang
Li, Yujia
Guo, Yi
Bradley, Julie Ann
Oladeru, Oluwadamilola Temilade
机构
[1] Univ Florida Hlth, Gainesville, FL USA
[2] Univ Florida, Dept Hlth Serv Res Management & Policy, Gainesville, FL USA
[3] Univ Florida, Gainesville, FL USA
[4] Univ Florida, Coll Med, Dept Radiat Oncol, Jacksonville, FL USA
[5] Univ Florida, Dept Radiat Oncol, Gainesville, FL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
75
引用
收藏
页码:75 / 75
页数:1
相关论文
共 50 条
  • [41] HEALTHCARE UTILIZATION AND COSTS IN LUNG CANCER PATIENTS WITH PRE-EXISTING COPD AMONG SEER-MEDICARE BENEFICIARIES
    Shah, S.
    Blanchette, C. M.
    Arthur, S.
    Coyle, J. P.
    Kowalkowski, M.
    Howden, R.
    VALUE IN HEALTH, 2017, 20 (05) : A360 - A360
  • [42] Trends in treatment among elderly colorectal cancer patients in the US: Evidence from linked SEER-Medicare data
    Lang, K.
    Lines, L. M.
    Lee, D. W.
    Korn, J. R.
    Vanness, D. J.
    Earle, C.
    Menzin, J.
    VALUE IN HEALTH, 2008, 11 (03) : A9 - A9
  • [43] Penile Implant Utilization Following Treatment for Prostate Cancer: Analysis of the SEER-Medicare Database
    Tal, Raanan
    Jacks, Lindsay M.
    Elkin, Elena
    Mulhall, John P.
    JOURNAL OF SEXUAL MEDICINE, 2011, 8 (06): : 1797 - 1804
  • [44] Hepatocellular carcinoma (HCC) survival by etiology: A SEER-Medicare database analysis.
    Brar, Gagandeep
    McNeel, Tim
    McGlynn, Katherine
    Graubard, Barry
    Floudas, Charalampos S.
    Morelli, M. Pia
    Xie, Changqing
    Greten, Tim F.
    Altekruse, Sean
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [45] THE INCIDENCE OF THROMBOCYTOPENIA AMONG OLDER PRIMARY MDS PATIENTS: A SEER-MEDICARE ANALYSIS
    Bennett, D.
    Shantakumar, S.
    Kobayashi, M.
    Wang, N.
    Snider, C.
    HAEMATOLOGICA, 2013, 98 : 431 - 432
  • [46] Is the number of TACE treatments in HCC patients associated with improved survival? A SEER-Medicare population analysis.
    Shaya, Fadia T.
    Breunig, Ian Michael
    Hanna, Nader
    Pandya, Naimish B.
    Chirikov, Viktor
    Seal, Brian S.
    Mullins, C. Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [47] TRENDS IN PREVALENCE, TREATMENT PATTERNS, MYELOSUPPRESSION, AND BURDEN ON THE HEALTHCARE SYSTEM AMONG PATIENTS WITH SMALL CELL LUNG CANCER: A SEER-MEDICARE ANALYSIS
    Epstein, R. S.
    Nelms, J.
    Moran, D.
    Girman, C.
    Krenitsky, J.
    Chioda, M.
    VALUE IN HEALTH, 2021, 24 : S66 - S66
  • [48] Current patterns and costs associated with oral and injectable therapy for metastatic breast cancer in US women: A SEER-Medicare analysis
    Rugo, Hope S.
    Clements, Karen
    McGarry, Lisa
    Faria, Claudio
    Teitelbaum, April H.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
  • [49] An assessment of the prevalence and incidence of comorbidities among patients with metastatic colorectal cancer in the United States using SEER-Medicare data
    Lowe, Kimberly
    Doant, Quan
    Gleeson, Michelle L.
    Kelsh, Michael Anthony
    Bohac, Gerry C.
    Danese, Mark D.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [50] SKELETAL-RELATED EVENTS AND MORTALITY AMONG SEER-MEDICARE PATIENTS WITH METASTATIC PROSTATE CANCER: THE IMPLICATIONS OF MEASUREMENT APPROACH
    Onukwugha, E.
    Yong, C.
    Mullins, C. D.
    Seal, B.
    Hussain, A.
    VALUE IN HEALTH, 2013, 16 (03) : A10 - A10